ESR1 and breast carcinoma: High expression profiles of each Bag-1 isoform have been observed mostly in estrogen receptor (ER) positive breast tumors and Bag-1L isoform prevents apoptosis via enhanced Bcl-2 expression in the presence of estrogen and trigger resistance phenotype in MCF-7 breast cancer cells [6].